News: Report Says Indian Biopharmas Lack as Innovation Partners


Jun 27, 2011

According to a report by the Boston Consulting Group, India's biopharmaceutical manufacturers, while performing relatively well in the minds of global biopharma executives, are still viewed as lacking in innovation. In addition, the report states that India still accounts for just roughly one percent of oversees R&D investment by U.S. biopharma companies.

Read on for BCG summary of the report, and for the news item in the Hindu Business Line.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments